Kodiak Sciences (KOD) EBT (2017 - 2026)
Kodiak Sciences (KOD) posted EBT of -$522.5 million for Q1 2026, down 35.73% on a QoQ basis from -$385.0 million in Q4 2025, and down 780.19% year-over-year from $76.8 million in Q1 2025.
Kodiak Sciences (KOD) EBT (2017 - 2026) Analysis & Trends
Kodiak Sciences' EBT history runs 10 years deep, the most recent figure standing at -$522.5 million for Q1 2026.
- Quarterly EBT fell 780.19% year-over-year to -$522.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.2 billion (down 512.96% YoY) and the FY2025 annual result came in at -$558.2 million, down 31.98% from the prior year.
- EBT was -$522.5 million for Q1 2026 at Kodiak Sciences, down from -$385.0 million in the prior quarter.
- Across five years, EBT topped out at -$44.8 million in Q1 2024 and bottomed at -$522.5 million in Q1 2026.
- A 5-year average of -$121.2 million and a median of -$71.1 million in 2022 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT soared 84.3% — and 2026, when it plunged 780.19%.
- Kodiak Sciences' EBT stood at -$71.1 million in 2022, then advanced by 15.04% to -$60.4 million in 2023, then grew by 25.54% to -$44.9 million in 2024, then tumbled by 756.48% to -$385.0 million in 2025, then sank by 35.73% to -$522.5 million in 2026.
- Business Quant data shows KOD's EBT at -$522.5 million in Q1 2026, -$385.0 million in Q4 2025, and -$228.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Kodiak Sciences | 2.56 Bn | 2.56 Bn | - | -522.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -522.55 Mn |
| Dec 31, 2025 | -384.98 Mn |
| Sep 30, 2025 | -228.01 Mn |
| Jun 30, 2025 | -60.04 Mn |
| Mar 31, 2025 | -59.37 Mn |
| Dec 31, 2024 | -44.95 Mn |
| Sep 30, 2024 | -45.11 Mn |
| Jun 30, 2024 | -45.62 Mn |
| Mar 31, 2024 | -44.77 Mn |
| Dec 31, 2023 | -60.36 Mn |
| Sep 30, 2023 | -50.31 Mn |
| Jun 30, 2023 | -85.17 Mn |
| Mar 31, 2023 | -74.50 Mn |
| Dec 31, 2022 | -71.05 Mn |
| Sep 30, 2022 | -83.64 Mn |
| Jun 30, 2022 | -97.02 Mn |
| Mar 31, 2022 | -102.26 Mn |
| Dec 31, 2021 | -93.03 Mn |
| Sep 30, 2021 | -498.78 Mn |
| Jun 30, 2021 | -502.79 Mn |